Paul Langerhans Institut Dresden

The program of the Paul Langerhans Institute Dresden (PLID) includes research into the pathophysiology of type 1 and type 2 diabetes mellitus. The main focus is on the mechanisms which cause the destruction and/or limited function of pancreatic beta cells and insufficient insulin secretion.
In addition, PLID also plays an outstanding role as only German transplant center for human pancreatic islet cells.

Associated groups

  • Prof. Dr. Dr. Michele Solimena
  • Dr. Tiago Alves
  • Prof. Dr. Ezio Bonifacio
  • Prof. Dr. Stefan Bornstein
  • Prof. Dr. Triantafyllos Chavakis
  • Prof. Dr. Ünal Coskun
  • Prof. Dr. Marius Distler
  • Prof. Dr. Anthony Gavalas
  • Dr. Anne Grapin-Botton
  • Prof. Dr. Barbara Ludwig
  • Prof. Dr. Nikolay Ninov
  • Prof. Dr. Nikolaos Perakakis
  • Dr. Tatiana Sandoval-Guzmán
  • Prof. Dr. Peter Schwarz
  • Prof. Dr. Stephan Speier
  • Prof. Dr. Jürgen Weitz


Contribution to the DZD research program

  • Transplantation of human pancreatic islets
  • Molecular mechanisms and systems biology of insulin granules
  • Identification of new therapy goals for increasing beta cell mass and insulin secretion
  • Functional beta cell imaging
  • Prevention and immune tolerance for type 1 diabetes
  • Prevention, genotyping and phenotypic characterization of type 2 diabetes
  • Participation in the clinical studies of the DZD


Michele Solimena, MD, PhD

Professor of Molecular Diabetology
Executive Director of the Paul Langerhans Institute Dresden


Paul Langerhans Institute Dresden of Helmholtz Munich at the University Hospital and Faculty of Medicine Carl Gustav Carus of TU Dresden
Fetscherstrasse 74
01307 Dresden

+49 (0)351 7963 6611